{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:36:45Z","timestamp":1793723805011,"version":"4.6.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1465-9921-12-161","type":"journal-article","created":{"date-parts":[[2011,12,29]],"date-time":"2011-12-29T19:21:08Z","timestamp":1325186468000},"source":"Crossref","is-referenced-by-count":57,"title":["Correlating changes in lung function with patient outcomes in chronic obstructive pulmonary disease: a pooled analysis"],"prefix":"10.1186","volume":"12","author":[{"given":"Paul W","family":"Jones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James F","family":"Donohue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry","family":"Nedelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Pascoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Pinault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Lassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,12,1]]},"reference":[{"key":"1191_CR1","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1183\/09031936.06.00145104","volume":"27","author":"PW Jones","year":"2006","unstructured":"Jones PW, Agusti AGN: Outcomes and markers in the assessment of chronic obstructive pulmonary disease. Eur Respir J. 2006, 27: 822-832. 10.1183\/09031936.06.00145104.","journal-title":"Eur Respir J"},{"key":"1191_CR2","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1157\/13098416","volume":"43","author":"FJ \u00c1lvarez-Guti\u00e9rrez","year":"2007","unstructured":"\u00c1lvarez-Guti\u00e9rrez FJ, Miravitlles M, Calle M, Gobartt E, L\u00f3pez F, Mart\u00edn A, Grupo de Estudio EIME: Impact of chronic obstructive pulmonary disease on activities of daily living: results of the EIME multicenter study. Arch Bronconeumol. 2007, 43: 64-72.","journal-title":"Arch Bronconeumol"},{"key":"1191_CR3","first-page":"245","volume":"4","author":"A Anzueto","year":"2009","unstructured":"Anzueto A, Leimer I, Kesten S: Impact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomes. Int J Chron Obstruct Pulmon Dis. 2009, 4: 245-251.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"1191_CR4","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1183\/09031936.00096108","volume":"33","author":"JP de Torres","year":"2009","unstructured":"de Torres JP, Cote CG, Lopez MV, Casanova C, D\u00edaz O, Marin JM, Pinto-Plata V, de Oca MM, Nekach H, Dordelly LJ, Aguirre-Jaime A, Celli BR: Sex differences in mortality in patients with COPD. Eur Respir J. 2009, 33: 528-535. 10.1183\/09031936.00096108.","journal-title":"Eur Respir J"},{"key":"1191_CR5","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1378\/chest.07-1342","volume":"133","author":"KH Groenewegen","year":"2008","unstructured":"Groenewegen KH, Postma DS, Hop WC, Wielders PL, Schl\u00f6sser NJ, Wouters EF, COSMIC Study Group: Increased systemic inflammation is a risk factor for COPD exacerbations. Chest. 2008, 133: 350-357. 10.1378\/chest.07-1342.","journal-title":"Chest"},{"key":"1191_CR6","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1183\/09031936.05.00078504","volume":"26","author":"G Gudmundsson","year":"2005","unstructured":"Gudmundsson G, Gislason T, Janson C, Lindberg E, Hallin R, Ulrik CS, Br\u00f8ndum E, Nieminen MM, Aine T, Bakke P: Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression. Eur Respir J. 2005, 26: 414-419. 10.1183\/09031936.05.00078504.","journal-title":"Eur Respir J"},{"key":"1191_CR7","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/1465-9921-7-109","volume":"7","author":"G Gudmundsson","year":"2006","unstructured":"Gudmundsson G, Gislason T, Lindberg E, Hallin R, Ulrik CS, Br\u00f8ndum E, Nieminen MM, Aine T, Bakke P, Janson C: Mortality in COPD patients discharged from hospital: the role of treatment and co-morbidity. Respir Res. 2006, 7: 109-10.1186\/1465-9921-7-109.","journal-title":"Respir Res"},{"key":"1191_CR8","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1136\/thx.2005.052449","volume":"61","author":"DM Mannino","year":"2006","unstructured":"Mannino DM, Davis KJ: Lung function decline and outcomes in an elderly population. Thorax. 2006, 61: 472-477. 10.1136\/thx.2005.052449.","journal-title":"Thorax"},{"key":"1191_CR9","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1080\/15412550600651263","volume":"3","author":"S McGlone","year":"2006","unstructured":"McGlone S, Venn A, Walters EH, Wood-Baker R: Physical activity, spirometry and quality-of-life in chronic obstructive pulmonary disease. COPD. 2006, 3: 83-88. 10.1080\/15412550600651263.","journal-title":"COPD"},{"key":"1191_CR10","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1378\/chest.06-1316","volume":"131","author":"DE Niewoehner","year":"2007","unstructured":"Niewoehner DE, Lokhyygina Y, Rice K, Kuschner WG, Sharafkhaneh A, Sarosi GA, Krumpe P, Pieper K, Kesten S: Risk indexes for exacerbations and hospitalizations due to COPD. Chest. 2007, 131: 20-28. 10.1378\/chest.06-1316.","journal-title":"Chest"},{"key":"1191_CR11","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1159\/000162877","volume":"77","author":"DE Niewoehner","year":"2009","unstructured":"Niewoehner DE: Relation of chronic obstructive pulmonary disease exacerbations to FEV1 - an intricate tango. Respiration. 2009, 77: 229-235. 10.1159\/000162877.","journal-title":"Respiration"},{"key":"1191_CR12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2332\/allergolint.O-06-431","volume":"56","author":"M Omata","year":"2007","unstructured":"Omata M, Wakabayashi R, Kudoh S, Kida K: Correlation between bronchodilator responsiveness and quality of life in chronic obstructive pulmonary disease. Allergol Int. 2007, 56: 15-22. 10.2332\/allergolint.O-06-431.","journal-title":"Allergol Int"},{"key":"1191_CR13","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1183\/09031936.06.00055805","volume":"28","author":"L Watson","year":"2006","unstructured":"Watson L, Schouten JP, Lofdahl CG, Pride NB, Laitinen LA, Postma DS, European Respiratory Society Study on Chronic Obstructive Pulmonary Disease: Predictors of COPD symptoms: does the sex of the patient matter?. Eur Respir J. 2006, 28: 311-318. 10.1183\/09031936.06.00055805.","journal-title":"Eur Respir J"},{"key":"1191_CR14","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1136\/thorax.56.11.880","volume":"56","author":"PW Jones","year":"2001","unstructured":"Jones PW: Health status measurement in chronic obstructive pulmonary disease. Thorax. 2001, 56: 880-887. 10.1136\/thorax.56.11.880.","journal-title":"Thorax"},{"key":"1191_CR15","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1465-9921-12-40","volume":"12","author":"M Westwood","year":"2011","unstructured":"Westwood M, Bourbeau J, Jones PW, Cerulli A, Capkun-Niggli G, Worthy G: Relationship between FEV1 change and patient-reported outcomes in randomised trials of inhaled bronchodilators for stable COPD: a systematic review. Respir Res. 2011, 12: 40-10.1186\/1465-9921-12-40.","journal-title":"Respir Res"},{"key":"1191_CR16","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1136\/thx.2009.125435","volume":"65","author":"R Dahl","year":"2010","unstructured":"Dahl R, Chung KF, Buhl R, Magnussen H, Nonikov V, Jack D, Bleasdale P, Owen R, Higgins M, Kramer B, on behalf of the INVOLVE (INdacaterol: Value in COPD, Longer Term Validation of Efficacy and Safety) Study Investigators: Efficacy of a new once-daily long-acting inhaled \u03b22-agonist indacaterol versus twice-daily formoterol in COPD. Thorax. 2010, 65: 473-479. 10.1136\/thx.2009.125435.","journal-title":"Thorax"},{"key":"1191_CR17","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1164\/rccm.200910-1500OC","volume":"182","author":"JF Donohue","year":"2010","unstructured":"Donohue JF, Fogarty C, L\u00f6tvall J, Mahler DA, Worth H, Yorgancio\u011flu A, Iqbal A, Swales J, Owen R, Higgins M, Kramer B, for the INHANCE Study Investigators: Once-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropium. Am J Respir Crit Care Med. 2010, 182: 155-162. 10.1164\/rccm.200910-1500OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"1191_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1471-2466-10-11","volume":"10","author":"G Feldman","year":"2010","unstructured":"Feldman G, Siler T, Prasad N, Jack D, Piggott S, Owen R, Higgins M, Kramer B, the INLIGHT 1 study group: Efficacy and safety of indacaterol 150 \u03bcg once-daily in COPD: a double-blind, randomised, 12-week study. BMC Pulm Med. 2010, 10: 11-10.1186\/1471-2466-10-11.","journal-title":"BMC Pulm Med"},{"key":"1191_CR19","unstructured":"Global initiative for chronic Obstructive Lung Disease (GOLD): Global Strategy for the Diagnosis, Management, and Prevention of chronic obstructive pulmonary disease. Date last updated: 2005 [ http:\/\/www.goldcopd.org\/Guidelines\/guidelines-global-strategy-for-diagnosis-management-2005.html ]"},{"key":"1191_CR20","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1183\/09031936.05.00034805","volume":"26","author":"MR Miller","year":"2005","unstructured":"Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CPM, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J: Standardisation of spirometry. Eur Respir J. 2005, 26: 319-338. 10.1183\/09031936.05.00034805.","journal-title":"Eur Respir J"},{"key":"1191_CR21","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1081\/COPD-200050513","volume":"2","author":"PW Jones","year":"2005","unstructured":"Jones PW: St. George's Respiratory Questionnaire: MCID. COPD. 2005, 2: 75-79. 10.1081\/COPD-200050513.","journal-title":"COPD"},{"key":"1191_CR22","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1081\/COPD-200050666","volume":"2","author":"DA Mahler","year":"2005","unstructured":"Mahler DA, Witek TJ: The MCID of the transition dyspnea index is a total score of one unit. COPD. 2005, 2: 99-103. 10.1081\/COPD-200050666.","journal-title":"COPD"},{"key":"1191_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4757-3462-1","volume-title":"Regression modeling strategies","author":"FE Harrell","year":"2001","unstructured":"Harrell FE: Regression modeling strategies. 2001, New York: Springer-Verlag"},{"key":"1191_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-21706-2","volume-title":"Modern applied statistics","author":"WN Venables","year":"2002","unstructured":"Venables WN, Ripley BD: Modern applied statistics. 2002, New York: Springer-Verlag"},{"key":"1191_CR25","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1081\/COPD-200053377","volume":"2","author":"J Donohue","year":"2005","unstructured":"Donohue J: Minimal clinically important differences in COPD lung function. COPD. 2005, 2: 111-124. 10.1081\/COPD-200053377.","journal-title":"COPD"},{"key":"1191_CR26","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/1465-9921-10-59","volume":"10","author":"CR Jenkins","year":"2009","unstructured":"Jenkins CR, Jones PW, Calverley PMA, Celli B, Anderson JA, Ferguson GT, Yates JC, Willits LR, Vestbo J: Efficacy of salmeterol\/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study. Respir Res. 2009, 10: 59-","journal-title":"Respir Res"},{"key":"1191_CR27","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1752-699X.2010.00198.x","volume":"5","author":"J Vestbo","year":"2011","unstructured":"Vestbo J, Anderson JA, Calverley PMA, Celli B, Ferguson GT, Jenkins C, Yates JC, Jones PW: Bias due to withdrawal in long-term randomised trials in COPD: evidence from the TORCH study. Clin Respir J. 2011, 5: 44-49. 10.1111\/j.1752-699X.2010.00198.x.","journal-title":"Clin Respir J"},{"key":"1191_CR28","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/S0140-6736(03)12459-2","volume":"361","author":"PMA Calverley","year":"2003","unstructured":"Calverley PMA, Pauwels R, Vestbo J, Jones PW, Pride N, Gulsvick A: Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease. Lancet. 2003, 361: 449-456. 10.1016\/S0140-6736(03)12459-2.","journal-title":"Lancet"},{"key":"1191_CR29","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1056\/NEJMoa063070","volume":"356","author":"PM Calverley","year":"2007","unstructured":"Calverley PM, Anderson JA, Celli BR, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J: Salmeterol and fluticasone proprionate and survival in chronic obstructive pulmonary disease. N Engl J Med. 2007, 356: 775-789. 10.1056\/NEJMoa063070.","journal-title":"N Engl J Med"},{"key":"1191_CR30","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1056\/NEJMoa0805800","volume":"359","author":"DP Tashkin","year":"2008","unstructured":"Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, Decramer M, UPLIFT Study Investigators: A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008, 359: 1543-1554. 10.1056\/NEJMoa0805800.","journal-title":"N Engl J Med"},{"key":"1191_CR31","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1183\/09031936.03.00020102","volume":"21","author":"F Di Marco","year":"2003","unstructured":"Di Marco F, Milic-Emili J, Boveri B, Carlucci P, Santus P, Casanova F, Cazzola M, Centanni S: Effect of inhaled bronchodilators on inspiratory capacity and dyspnoea at rest in COPD. Eur Respir J. 2003, 21: 86-94. 10.1183\/09031936.03.00020102.","journal-title":"Eur Respir J"},{"key":"1191_CR32","unstructured":"Global initiative for chronic Obstructive Lung Disease (GOLD): Global Strategy for the Diagnosis, Management, and Prevention of chronic obstructive pulmonary disease. Date last updated: 2010 [ http:\/\/www.goldcopd.com ]"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1465-9921-12-161.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1465-9921-12-161\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1465-9921-12-161.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,5]],"date-time":"2016-10-05T16:51:22Z","timestamp":1475686282000},"score":1,"resource":{"primary":{"URL":"http:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/1465-9921-12-161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["1191"],"URL":"https:\/\/doi.org\/10.1186\/1465-9921-12-161","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12]]},"article-number":"161"}}